Early bone mineral density changes in treatment-naïve clinically isolated syndrome and relapsing-remitting multiple sclerosis

Background Low bone mineral density (BMD), osteopenia, osteoporosis, and fracture risk are increasingly recognized in multiple sclerosis, but data on early bone loss remain limited. We aimed to assess low BMD prevalence in newly diagnosed, treatment-naïve clinically isolated syndrome or relapsing-remitting multiple sclerosis (CIS/RRMS) patients and explore associations with clinical features and cerebrospinal fluid (CSF) immune markers. Methods This retrospective study included 76 treatment-naïve patients with CIS/RRMS who underwent dual-energy X-ray absorptiometry and CSF analysis. Patients with comorbidities, medication use, or major exposures potentially affecting BMD were excluded. Lumbar spine, femoral neck, and total femur BMD, T-scores, and Z-scores were evaluated, with BMD adjusted for age, sex, and body mass index. Associations with clinical onset characteristics, biochemical variables, and CSF immune markers were analyzed. Results The mean age was 32.9±9.52 years, and the mean baseline Expanded Disability Status Scale score was 1.29±0.89. BMD below the expected range for age was detected in 12 patients (15.8%). Femoral neck Z-score was nominally lower in patients with optic neuritis involvement at onset, while adjusted lumbar BMD was nominally higher in patients with an IgG index <0.7(p=0.037). However, these exploratory associations did not remain significant after correction. Conclusion Bone health may be affected from the early stages of CIS/RRMS, even in treatment-naïve patients with low disability and limited confounding factors. The regional differences observed between the femoral and lumbar sites, together with the borderline nominal trends with CSF-based immunological markers, suggest that the potential relationship between early neuroinflammatory processes and bone metabolism warrants further confirmation in prospective studies.

Authors

Institutions

Publication Details

Journal
Frontiers in Endocrinology
Published
2026-11-18
DOI
https://doi.org/10.3389/fendo.2026.1952659
Primary Topic
Multiple Sclerosis Research Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Early bone mineral density changes in treatment-naïve clinically isolated syndrome and relapsing-remitting multiple sclerosis

Soner Cander, Filiz Mercan Sarıdaş, Güven Özkaya, Emine Rabia Koç et al.
1 links
Frontiers in Endocrinology
Multiple Sclerosis Research Studies
article

Early bone mineral density changes in treatment-naïve clinically isolated syndrome and relapsing-remitting multiple sclerosis

Soner Cander, Filiz Mercan Sarıdaş, Güven Özkaya, Emine Rabia Koç, Furkan Sarıdaş, Özen Öz Gül
article en

Abstract

Background Low bone mineral density (BMD), osteopenia, osteoporosis, and fracture risk are increasingly recognized in multiple sclerosis, but data on early bone loss remain limited. We aimed to assess low BMD prevalence in newly diagnosed, treatment-naïve clinically isolated syndrome or relapsing-remitting multiple sclerosis (CIS/RRMS) patients and explore associations with clinical features and cerebrospinal fluid (CSF) immune markers. Methods This retrospective study included 76 treatment-naïve patients with CIS/RRMS who underwent dual-energy X-ray absorptiometry and CSF analysis. Patients with comorbidities, medication use, or major exposures potentially affecting BMD were excluded. Lumbar spine, femoral neck, and total femur BMD, T-scores, and Z-scores were evaluated, with BMD adjusted for age, sex, and body mass index. Associations with clinical onset characteristics, biochemical variables, and CSF immune markers were analyzed. Results The mean age was 32.9±9.52 years, and the mean baseline Expanded Disability Status Scale score was 1.29±0.89. BMD below the expected range for age was detected in 12 patients (15.8%). Femoral neck Z-score was nominally lower in patients with optic neuritis involvement at onset, while adjusted lumbar BMD was nominally higher in patients with an IgG index <0.7(p=0.037). However, these exploratory associations did not remain significant after correction. Conclusion Bone health may be affected from the early stages of CIS/RRMS, even in treatment-naïve patients with low disability and limited confounding factors. The regional differences observed between the femoral and lumbar sites, together with the borderline nominal trends with CSF-based immunological markers, suggest that the potential relationship between early neuroinflammatory processes and bone metabolism warrants further confirmation in prospective studies.

Frontiers in EndocrinologyVol. 17
Bursa Uludağ Üni̇versi̇tesi̇ (TR)
Good health and well-being
Multiple Sclerosis Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon